Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway.
Aas CF, Vold JH, Skurtveit S, Lim AG, Ruths S, Islam K, Askildsen JE, Løberg EM, Fadnes LT, Johansson KA; INTRO-HCV Study Group. Aas CF, et al. Among authors: johansson ka. Subst Abuse Treat Prev Policy. 2020 Sep 3;15(1):68. doi: 10.1186/s13011-020-00309-y. Subst Abuse Treat Prev Policy. 2020. PMID: 32883319 Free PMC article.
Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study.
Vold JH, Halmøy A, Chalabianloo F, Pierron MC, Løberg EM, Johansson KA, Fadnes LT. Vold JH, et al. Among authors: johansson ka. BMC Psychiatry. 2023 Jun 29;23(1):479. doi: 10.1186/s12888-023-04980-w. BMC Psychiatry. 2023. PMID: 37386438 Free PMC article.
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).
Fadnes LT, Aas CF, Vold JH, Ohldieck C, Leiva RA, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA; INTRO-HCV Study Group. Fadnes LT, et al. Among authors: johansson ka. BMC Infect Dis. 2019 Nov 8;19(1):943. doi: 10.1186/s12879-019-4598-7. BMC Infect Dis. 2019. PMID: 31703669 Free PMC article. Clinical Trial.
Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway.
Lygren OJ, Bjørnestad R, Løberg EM, Bonnier ML, Buljovcic VB, Johansson KA, Fadnes LT; INTRO-HCV Study Group. Lygren OJ, et al. Among authors: johansson ka. Subst Abuse Treat Prev Policy. 2019 Dec 21;14(1):58. doi: 10.1186/s13011-019-0245-y. Subst Abuse Treat Prev Policy. 2019. PMID: 31864396 Free PMC article.
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016-2020.
Vold JH, Gjestad R, Aas CF, Chalabianloo F, Skurtveit S, Løberg EM, Johansson KA, Fadnes LT; INTRO-HCV Study Group. Vold JH, et al. Among authors: johansson ka. Subst Abuse Treat Prev Policy. 2020 Dec 14;15(1):93. doi: 10.1186/s13011-020-00334-x. Subst Abuse Treat Prev Policy. 2020. PMID: 33317568 Free PMC article.
212 results